Rxsight Inc (RXST) - Total Assets
Based on the latest financial reports, Rxsight Inc (RXST) holds total assets worth $308.53 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Rxsight Inc net assets for net asset value and shareholders' equity analysis.
Rxsight Inc - Total Assets Trend (2019–2024)
This chart illustrates how Rxsight Inc's total assets have evolved over time, based on quarterly financial data.
Rxsight Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Rxsight Inc's total assets of $308.53 Million consist of 92.2% current assets and 7.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 5.2% |
| Accounts Receivable | $30.05 Million | 9.4% |
| Inventory | $22.01 Million | 6.9% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2019–2024)
This chart illustrates how Rxsight Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Rxsight Inc market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Rxsight Inc's current assets represent 92.2% of total assets in 2024, an increase from 81.7% in 2019.
- Cash Position: Cash and equivalents constituted 5.2% of total assets in 2024, down from 7.2% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2019.
- Asset Diversification: The largest asset category is accounts receivable at 9.4% of total assets.
Rxsight Inc Competitors by Total Assets
Key competitors of Rxsight Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
INKON Life Technology Co Ltd
SHE:300143
|
China | CN¥4.15 Billion |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607
|
China | CN¥988.48 Million |
|
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS
|
USA | $139.92 Million |
|
Universus Photo Imagings Limited
NSE:UNIVPHOTO
|
India | Rs8.57 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
|
Aligned Genetics Inc
KQ:238120
|
Korea | ₩45.11 Billion |
|
Heramed Ltd
AU:HMD
|
Australia | AU$1.04 Million |
|
Acarix A/S
ST:ACARIX
|
Sweden | Skr48.33 Million |
Rxsight Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 12.74 | 12.67 | 7.03 |
| Quick Ratio | 11.44 | 11.71 | 6.31 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $261.59 Million | $264.13 Million | $69.90 Million |
Rxsight Inc - Advanced Valuation Insights
This section examines the relationship between Rxsight Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.23 |
| Latest Market Cap to Assets Ratio | 0.96 |
| Asset Growth Rate (YoY) | 74.5% |
| Total Assets | $318.56 Million |
| Market Capitalization | $304.26 Million USD |
Valuation Analysis
Near Book Valuation: The market values Rxsight Inc's assets close to their book value (0.96x), suggesting investors view the company's assets at approximately fair value.
Rapid Asset Growth: Rxsight Inc's assets grew by 74.5% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Rxsight Inc (2019–2024)
The table below shows the annual total assets of Rxsight Inc from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $318.56 Million | +74.51% |
| 2023-12-31 | $182.55 Million | +21.57% |
| 2022-12-31 | $150.16 Million | -22.08% |
| 2021-12-31 | $192.72 Million | +91.43% |
| 2020-12-31 | $100.68 Million | -8.83% |
| 2019-12-31 | $110.43 Million | -- |
About Rxsight Inc
RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adju… Read more